Welcome to our dedicated page for Delphx Cap Mkts news (Ticker: DPXCF), a resource for investors and traders seeking the latest updates and insights on Delphx Cap Mkts stock.
DelphX Capital Markets Inc. develops structured-product technology and financial services for broker-dealers. Through its special purpose vehicle Quantem LLC, the company enables private placement securities designed for fixed-income and cryptocurrency-based solutions, including Collateralized Put Options and Collateralized Reference Notes. News about DPXCF commonly covers non-brokered unit private placements, common-share and warrant terms, TSX Venture Exchange-related conditions, stock option grants under its option plan, and updates tied to structured-product distribution.
DelphX Capital Markets (OTCQB: DPXCF) closed a non-brokered unit private placement on April 29, 2026, issuing 3,000,000 units at C$0.04 per unit for gross proceeds of C$120,000. Each unit includes one common share and one warrant exercisable at $0.08 for two years.
Securities are subject to TSXV approval and a four-month plus one-day hold. Net proceeds are intended for working capital and corporate overhead.
DelphX Capital Markets (OTCQB: DPXCF) announced a non-brokered private placement of up to 3,750,000 Units at C$0.04 per Unit to raise up to C$150,000 in gross proceeds. Each Unit comprises one common share and one warrant exercisable at C$0.08 for two years.
The Offering is subject to TSX Venture Exchange approval, securities will carry a four-month-plus-one-day hold period, finder's fees may be paid, insiders may participate subject to insider trading policy, and net proceeds are intended for general corporate purposes.
DelphX (OTCQB: DPXCF) announced that its board approved a grant of 1,450,000 stock options under its stock option plan on March 25, 2026. The Options have a two-year maturity and are exercisable at $0.08 per share.
700,000 Options were granted to insiders, including board members and executive officers, and all grants are in accordance with the Plan.
DelphX (OTCQB:DPXCF) provided a strategic update on its Bitcoin treasury initiative and institutional financing on March 24, 2026. The company is in final discussions for a senior secured lending facility with a major digital asset lender and plans a complementary USD $18M convertible debenture placement.
DelphX expects an initial capital deployment of ~USD $50M via a rules-based monthly tranche program and intends to embed its Quantem Collateralized Securities (QCS) platform to manage structured Bitcoin exposure.
DelphX (OTCQB: DPXCF; TSXV: DELX) closed a non‑brokered unit private placement on March 20, 2026, issuing 4,360,000 units at C$0.05 per unit for gross proceeds of C$218,000. Each unit includes one common share and one warrant exercisable at C$0.08 for two years. Securities are subject to a four‑month plus one‑day hold and completion is subject to TSX Venture Exchange approval. Net proceeds are intended for working capital and corporate overhead.
DelphX (OTCQB: DPXCF; TSXV: DELX) announced a non-brokered private placement of up to 2,500,000 units at C$0.05 per unit to raise up to C$125,000. Each unit includes one common share and one warrant exercisable at C$0.08 for two years.
Completion is subject to TSX Venture Exchange approval, securities will have a four-month-plus-one-day hold, insiders may participate, finder's fees may be paid, and net proceeds are for general corporate purposes.
DelphX Capital Markets (OTCQB: DPXCF) closed a non-brokered unit private placement issuing 4,100,000 units at C$0.05 per unit for gross proceeds of C$205,000 on Feb 25, 2026.
Each unit includes one common share and one warrant exercisable at $0.08 for two years; securities are subject to TSX Venture Exchange approval and a four-month plus one-day hold period. Net proceeds will be used for working capital and corporate overhead.
DelphX (OTCQB: DPXCF) intends a non-brokered private placement of up to 5,000,000 Units at C$0.05 per Unit to raise up to C$250,000 gross. Each Unit includes one common share and one warrant exercisable at C$0.08 for two years. Securities will be subject to a four-month plus one-day hold period and the Offering requires TSX Venture Exchange approval. DelphX may pay finder’s fees and insiders may participate, with net proceeds earmarked for general corporate purposes.
DelphX (OTCQB: DPXCF) intends to seek TSX Venture Exchange approval to extend the exercise period of 3,904,166 share purchase warrants exercisable at $0.20 by one year to January 30, 2027. All other warrant terms remain unchanged and the extension is subject to TSXV acceptance.
A total of 1,208,333 warrants are held by related parties, making the amendment a related party transaction under MI 61-101 and TSXV Policy 5.9, but exemptions for formal valuation and minority approval apply because the warrants' fair market value does not exceed 25% of DelphX market capitalization.
DelphX (OTCQB: DPXCF) closed a non-brokered unit private placement on January 30, 2026, issuing 3,000,000 Units at C$0.05 per Unit for gross proceeds of C$150,000. Each Unit includes one common share and one warrant exercisable at $0.08 for two years.
An insider subscribed for all 3,000,000 Units, making the transaction a related party participation under MI 61-101; DelphX relied on exemptions to formal valuation and minority approval. Closing remains subject to TSX Venture Exchange approval and issued securities carry a four-month-plus-one-day hold. Net proceeds are intended for working capital and corporate overhead.